---
figid: PMC4863577__jep-4-173Fig1
figtitle: 'Hh pathway critical components which could be targeted by potential antibasal
  cell carcinoma drugs.Notes: The mechanism of action of each single drug is explained
  in the text'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4863577
filename: jep-4-173Fig1.jpg
figlink: /pmc/articles/PMC4863577/figure/f1-jep-4-173/
number: F1
caption: 'The Hh pathway critical components which could be targeted by potential
  antibasal cell carcinoma drugs.Notes: The mechanism of action of each single drug
  is explained in the text. The question mark indicates a so far undetermined mechanism.
  The EGFR and PI3K pathways are also sketched, given their potential contribution
  to Hh pathway tumorigenic activity.Abbreviations: Ac, acetyl group; Ch, cholesterol;
  EGFR, epidermal growth factor receptor; ERK, extracellular signal-related kinase;
  GANT, Gli antagonist; Hdac, histone deacetylase; Hh, Hedgehog; HPI, Hedgehog pathway
  inhibitor; KCASH, KCTD (Potassium Channel Tetramerization Domain) containing cullin3
  adaptor suppressor of hedgehog; MEK, mitogen-activated protein kinase kinase; P,
  palmitate; PI3K, phosphatidylinositol 3-kinase; PKB/akt, protein kinase B; Ptch,
  Patched; Quinaz, quinazolines; Robotk, robotnikinin; Smo, Smoothened; SuFu, suppressor
  of fused; TSA, trichostatin A; VitD3, Vitamine D3.'
papertitle: Hedgehog signaling pathway and its targets for treatment in basal cell
  carcinoma.
reftext: Danilo Cucchi, et al. J Exp Pharmacol. 2012;4:173-185.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.938003
figid_alias: PMC4863577__F1
figtype: Figure
redirect_from: /figures/PMC4863577__F1
ndex: 2b8b5c69-df07-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4863577__jep-4-173Fig1.html
  '@type': Dataset
  description: 'The Hh pathway critical components which could be targeted by potential
    antibasal cell carcinoma drugs.Notes: The mechanism of action of each single drug
    is explained in the text. The question mark indicates a so far undetermined mechanism.
    The EGFR and PI3K pathways are also sketched, given their potential contribution
    to Hh pathway tumorigenic activity.Abbreviations: Ac, acetyl group; Ch, cholesterol;
    EGFR, epidermal growth factor receptor; ERK, extracellular signal-related kinase;
    GANT, Gli antagonist; Hdac, histone deacetylase; Hh, Hedgehog; HPI, Hedgehog pathway
    inhibitor; KCASH, KCTD (Potassium Channel Tetramerization Domain) containing cullin3
    adaptor suppressor of hedgehog; MEK, mitogen-activated protein kinase kinase;
    P, palmitate; PI3K, phosphatidylinositol 3-kinase; PKB/akt, protein kinase B;
    Ptch, Patched; Quinaz, quinazolines; Robotk, robotnikinin; Smo, Smoothened; SuFu,
    suppressor of fused; TSA, trichostatin A; VitD3, Vitamine D3.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Egfr
  - Gli
  - ci
  - Su(fu)
  - hh
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - ac
  - HDAC4
  - HDAC6
  - HDAC1
  - HDAC3
  - Akt
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - ptc
  - smo
  - sm
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EGFR
  - GLI1
  - SUFU
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - HDAC9
  - HDAC2
  - HDAC8
  - HDAC5
  - HDAC7
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - PRDX2
  - AKT1
  - PTK2B
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - PTCH1
  - SMO
  - SMOX
  - Cyclopamine
  - IPI-926
  - Saridegib
  - Bis-amides
  - Retinoids
  - Itraconazole
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
